Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_assertion type Assertion NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_head.
- NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_assertion description "[MMP-2, MMP-9, MT1-MMP and TIMP-2 are valid markers of poor survival in advanced-stage ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_provenance.
- NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_assertion evidence source_evidence_literature NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_provenance.
- NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_assertion SIO_000772 11988310 NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_provenance.
- NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_assertion wasDerivedFrom befree-20140225 NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_provenance.
- NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_assertion wasGeneratedBy ECO_0000203 NP516625.RApYOD5XRPwRnlB7nyjur_DjpKXiN3iJX0dqTnmgpiRU4130_provenance.